Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azimilide in symptomatic atrial fibrillation
NCT00035464Phase 3Completed
- Sponsor
- Forest Laboratories
- Start
- Dec 2000
- Primary completion
- Jan 2004
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azimilide in Atrial fibrillation (AFib), sponsored by Forest Laboratories. Started Dec 2000; status: completed.
02
Drugs
azimilide
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT00035464.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00035464.